CARRIE BOWLING: Open Payments
NPI 1720017692 · VALDOSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$377 in 19 payments from 11 companies in 2025. Trend: 2023 $258 · 2024 $577 · 2025 $377
Food & beverage: $377
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 3 | $63 |
| Amneal Pharmaceuticals LLC | 4 | $61 |
| Dexcom, Inc. | 2 | $50 |
| Ascendis Pharma Endocrinology Inc | 2 | $44 |
| Corcept Therapeutics | 2 | $43 |
| Radius Health, Inc. | 1 | $24 |
| Tandem Diabetes Care, Inc. | 1 | $23 |
| Insulet Corporation | 1 | $21 |
| Chiesi USA, Inc. | 1 | $18 |
| Novo Nordisk Inc | 1 | $15 |
Products named: UNITHROID, Dexcom G6 Transmitter, Yorvipath, Korlym, EVENITY, Tymlos, t:slim X2 Insulin Pump with Control-IQ, TEPEZZA.
Industry payments across GA — which companies pay providers there.
